BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hampe CS. Protective role of anti-idiotypic antibodies in autoimmunity – Lessons for type 1 diabetes. Autoimmunity 2012;45:320-31. [DOI: 10.3109/08916934.2012.659299] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I. CD8+ T-cell auto-reactivity is dependent on the expression of the immunoproteasome subunit LMP7 in exposed to lipopolysaccharide antigen presenting cells and epithelial target cells. Autoimmunity 2013;46:439-45. [DOI: 10.3109/08916934.2013.801460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
2 Elsanhoury A, Tschöpe C, Van Linthout S. A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy. J Cardiovasc Transl Res 2021;14:75-87. [PMID: 32440911 DOI: 10.1007/s12265-020-10025-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Munder A, Moskovitz Y, Meir A, Kahremany S, Levy L, Kolitz-Domb M, Cohen G, Shtriker E, Viskind O, Lellouche JP, Senderowitz H, Chessler SD, Korshin EE, Ruthstein S, Gruzman A. Neuroligin-2-derived peptide-covered polyamidoamine-based (PAMAM) dendrimers enhance pancreatic β-cells' proliferation and functions. Medchemcomm 2019;10:280-93. [PMID: 30881615 DOI: 10.1039/c8md00419f] [Reference Citation Analysis]
4 Thyagarajan R, Banday V, Ding Z, Lejon K. Contribution of autoallergy to the pathogenesis in the NOD mice. Autoimmunity 2015;48:298-304. [PMID: 25707684 DOI: 10.3109/08916934.2015.1016220] [Reference Citation Analysis]
5 Landmann S, Preuss N, Behn U. Self-tolerance and autoimmunity in a minimal model of the idiotypic network. Journal of Theoretical Biology 2017;426:17-39. [DOI: 10.1016/j.jtbi.2017.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Thorsen SU, Pipper CB, Mortensen HB, Pociot F, Johannesen J, Svensson J. No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study. Int J Endocrinol 2016;2016:8350158. [PMID: 27818684 DOI: 10.1155/2016/8350158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Pan SY, Chia YC, Yee HR, Fang Cheng AY, Anjum CE, Kenisi Y, Chan MK, Wong MB. Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases. Future Sci OA 2020;7:FSO648. [PMID: 33437514 DOI: 10.2144/fsoa-2020-0142] [Reference Citation Analysis]
8 Schulz R, Werner B, Behn U. Self-tolerance in a minimal model of the idiotypic network. Front Immunol 2014;5:86. [PMID: 24653720 DOI: 10.3389/fimmu.2014.00086] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
9 Luan L, Xue R, Lu C, Cui A, Hou Y, Quan J, Xiang M, Wang X, Yuan W, Sun N, Meng D, Chen S. Anti-serum with anti-autoantibody activity decreases autoantibody-positive B lymphocytes and type 1 diabetes of female NOD mice. Autoimmunity 2016;49:21-30. [PMID: 26334951 DOI: 10.3109/08916934.2015.1079819] [Reference Citation Analysis]
10 Moritz CP, Stoevesandt O, Tholance Y, Camdessanché JP, Antoine JC. Proper definition of the set of autoantibody-targeted antigens relies on appropriate reference group selection. N Biotechnol 2021;60:168-72. [PMID: 33045420 DOI: 10.1016/j.nbt.2020.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Felton JL, Maseda D, Bonami RH, Hulbert C, Thomas JW. Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 Diabetes. J Immunol 2018;201:861-73. [PMID: 29950508 DOI: 10.4049/jimmunol.1701717] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
12 Selmi C. Autoimmunity in 2012. Clin Rev Allergy Immunol 2013;45:290-301. [PMID: 23975606 DOI: 10.1007/s12016-013-8386-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
13 Martínez D, Pupo A, Cabrera L, Raymond J, Holodick NE, Hernández AM. B-CD8+ T Cell Interactions in the Anti-Idiotypic Response against a Self-Antibody. J Immunol Res 2017;2017:2860867. [PMID: 28491873 DOI: 10.1155/2017/2860867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Quaglia S, Ferrara F, De Leo L, Ziberna F, Vatta S, Marchiò S, Sblattero D, Ventura A, Not T. A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies. J Immunol 2019;202:1079-87. [PMID: 30635394 DOI: 10.4049/jimmunol.1800819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yang Y, Su X, Zhang K, Zhou R. The Fc receptor-like 3 gene polymorphisms and susceptibility to autoimmune diseases: An updated meta-analysis. Autoimmunity 2013;46:547-58. [DOI: 10.3109/08916934.2013.835804] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
16 Rowley M, Whittingham S. The Role of Pathogenic Autoantibodies in Autoimmunity. Antibodies 2015;4:314-53. [DOI: 10.3390/antib4040314] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang M, Yang F, Huang D, Huang Y, Zhang X, Wang C, Zhang S, Zhang R. Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection. Front Cell Infect Microbiol 2017;7:157. [PMID: 28536674 DOI: 10.3389/fcimb.2017.00157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 Zóka A, Műzes G, Somogyi A, Varga T, Szémán B, Al-Aissa Z, Hadarits O, Firneisz G. Altered immune regulation in type 1 diabetes. Clin Dev Immunol 2013;2013:254874. [PMID: 24285974 DOI: 10.1155/2013/254874] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
19 Larsson HE, Jönsson I, Lernmark A, Ivarsson S, Radtke JR, Hampe CS; Diabetes Prediction in Skåne (DiPiS)., Type 1 Diabetes Trial Network. Decline in titers of anti-idiotypic antibodies specific to autoantibodies to GAD65 (GAD65Ab) precedes development of GAD65Ab and type 1 diabetes. PLoS One 2013;8:e65173. [PMID: 23785410 DOI: 10.1371/journal.pone.0065173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Richardson CC, McLaughlin KA, Brown TJ, Morgan D, Feltbower R, Powell M, Furmaniak J, Rees Smith B, Christie MR. Failure to detect anti-idiotypic antibodies in the autoimmune response to IA-2 in Type 1 diabetes. Autoimmunity 2013;46:375-81. [PMID: 24001205 DOI: 10.3109/08916934.2013.773978] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
21 Stene LC, Gale EA. The prenatal environment and type 1 diabetes. Diabetologia. 2013;56:1888-1897. [PMID: 23657800 DOI: 10.1007/s00125-013-2929-6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
22 Zóka A, Somogyi A, Firneisz G. [Type 1 diabetes mellitus: most recent advances in its pathogenesis and treatment]. Orv Hetil 2012;153:1047-56. [PMID: 22759745 DOI: 10.1556/OH.2012.29413] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Li M, Song LJ, Qin XY. Advances in the cellular immunological pathogenesis of type 1 diabetes. J Cell Mol Med. 2014;18:749-758. [PMID: 24629100 DOI: 10.1111/jcmm.12270] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
24 Leung D, Wurst JM, Liu T, Martinez RM, Datta-Mannan A, Feng Y. Antibody Conjugates-Recent Advances and Future Innovations. Antibodies (Basel) 2020;9:E2. [PMID: 31936270 DOI: 10.3390/antib9010002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
25 Yasunaga M, Manabe S, Furuta M, Ogata K, Koga Y, Takashima H, Nishida T, Matsumura Y; 1 Division of Developmental Therapeutics, EPOC, National Cancer Center (6-5-1 Kashiwanoha, Kashiwa-shi, Chiba 277-8577, Japan), Japan, 2 Synthetic Cellular Chemistry Laboratory, RIKEN (Hirosawa, Wako, Saitama 351-0198, Japan), Japanbr, 3 Shimadzu Corporation (1, Nishinokyo-Kuwabaracho, Nakagyo-ku, Kyoto 604-8511, Japan), Japanbr, 4 National Cancer Center Hospital (5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan), Japan. . AIMS Medical Science 2018;5:162-80. [DOI: 10.3934/medsci.2018.2.162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Geale PF, Sheehy PA, Giles C, Thomson PC, Wynn PC. Efficacy of two adjuvant systems to promote humoral immunity to the pre-proghrelin peptide obestatin in pigs: consequences for the growth of piglets to weaning. Anim Prod Sci 2020;60:356. [DOI: 10.1071/an18404] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]